Bicycle Therapeutics (BCYC) Enterprise Value (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Bicycle Therapeutics | 326.82 Mn | 326.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.92% |
| Dec 31, 2025 | 3.11% |
| Sep 30, 2025 | 10.15% |
| Jun 30, 2025 | 9.01% |
| Mar 31, 2025 | -19.26% |
| Dec 31, 2024 | 25.36% |
| Sep 30, 2024 | 7.33% |
| Jun 30, 2024 | -110.37% |
| Mar 31, 2024 | 13.19% |
| Dec 31, 2023 | 7.98% |
| Sep 30, 2023 | -68.05% |
| Jun 30, 2023 | -15.87% |
| Mar 31, 2023 | 13.37% |
| Dec 31, 2022 | 6.17% |
| Sep 30, 2022 | 3.04% |
| Jun 30, 2022 | -272.80% |
| Mar 31, 2022 | 77.20% |
| Jun 30, 2021 | -1.45% |
| Mar 31, 2021 | -44.06% |
| Dec 31, 2020 | 9.24% |
| Sep 30, 2020 | -54.62% |
| Jun 30, 2020 | 11.61% |
| Mar 31, 2020 | -19.02% |
| Dec 31, 2019 | 4.00% |
| Sep 30, 2019 | 11.59% |
| Jun 30, 2019 | -82.83% |
| Mar 31, 2019 | 6.34% |
| Dec 31, 2018 | -32.26% |
| Sep 30, 2018 | 10.27% |